Ieramilimab Uses, Dosage, Side Effects and more
Ieramilimab is under investigation in clinical trial NCT02460224 (Safety and Efficacy of LAG525 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.).
| Trade Name | Ieramilimab |
| Generic | Ieramilimab |
| Ieramilimab Other Names | Ieramilimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
